ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

N4P N4 Pharma Plc

0.85
0.125 (17.24%)
15 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
N4 Pharma Plc LSE:N4P London Ordinary Share GB00BYW8QM32 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.125 17.24% 0.85 0.80 0.90 0.925 0.775 0.78 2,667,253 11:38:39
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Drug & Proprietary Stores 0 -1.03M -0.0057 -1.49 1.54M
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.73p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.20p.

N4 Pharma currently has 181,080,349 shares in issue. The market capitalisation of N4 Pharma is £1.54 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.49.

N4 Pharma Share Discussion Threads

Showing 4501 to 4523 of 8575 messages
Chat Pages: Latest  187  186  185  184  183  182  181  180  179  178  177  176  Older
DateSubjectAuthorDiscuss
13/8/2018
10:36
Nobbygnome - 24 Jul 2018 - 20:09:24 - 334 of 644

N4 Pharma - N4P



As always I will be trading as well as holding some for the long term. With N4P I had decided there was no real future and was in the process of selling out. However, I was too greedy and was left with 10k, which I still have. C'est la vie....

Nobby

hughwilson
13/8/2018
10:30
Misinformation yet again, professional investor not trader! Is your real name Donald Trump; you are so good at fake news!
nobbygnome
13/8/2018
10:29
That is your ultimate naive statement. So do you really think beloved Nigel would say 'yes we are planning to do a fund raising next month'. LOL talk about naive. There will be a pregnant pause ahead of a fund raising but I would guess in about 2-3 months, one will appear.

I am not quite sure how I can apologise for something in the future.....but you can certainly apologise for something in the past!

nobbygnome
13/8/2018
10:26
"I am now a very successful professional investor"

Finally Nobby has admitted that he is a professional trader.
Everything he says can be taken with a pinch of salt because it will be the result of his agenda.

As for a professional investor, I think that you have already proved that you are not an investor at all and certainly not long-term, you are a trader and a pump & dump merchant and no more.

hughwilson
13/8/2018
10:19
Nobbo, any apology from you in saying that the next thing we will see is a cash call when I have asked Nigel about this and it is totally false- NO
Any apology from you in saying that the company is in trouble when in fact it is well funded- NO.
Any apology from you in saying that the company had not budgeted for a retrial when it has-No.
So I could go on.
Nothing but lies and misinformation from someone who claims to know everything.

hughwilson
13/8/2018
10:05
Oh and still no apology for your generic statement lies...
nobbygnome
13/8/2018
10:03
LOL talk about personal attacks! You are correct in as much as I might buy in the next fund raising at 5p..... Now that is probably a stupid thing to write because the sad person that you are, you will quote it in every other post hence forward. However, I am going to leave it in because by doing that you will prove what a sad person you are!

I will continue to post because strangely this is a free country and as an informed ex Pharma employee, I feel the urge to counter your constant misinformation. And I am now a very successful professional investor and you should watch and learn 😜! The only way to overcome your naivety is to learn from experienced investors.

Nobby

nobbygnome
13/8/2018
09:20
Nobbo, you are a cheap two-bit trader and no more. You have £700 of N4 and even that is because you failed to sell them all and yet you spend all day here trying to de ramp the company and anyone who is positive. I would have more respect for you if you were to admit that you wanted the price lower so that you could load up. If you were that negative on the company then you would sell your pittance of a holding and move on but as a trader you seek to load up again which means that you are not quite so negative about the company's future as you currently make out. Must admit that I was really disappointed by the quality of your ramping on other stocks, I would have expected better of you.
hughwilson
12/8/2018
19:05
Oh and please can you apologise for your incorrect generics statement?
nobbygnome
12/8/2018
19:00
Oh dear you are becoming obsessed with my posts hugh! And as usual you are misleading everybody, I am a LTH in most cases who trades around the edges.

Plus I call it right on biotechs regularly unlike you......but hey, as usual don't let the truth get in the way of a good story. And that statement sums you up!

Nobby

nobbygnome
12/8/2018
18:32
Nobbo, having reviewed some of your posts on other shares, please don`t call me a ramper ever again.Your ramps are cheap and are on a par with your deramps here. I now understand that you are just a trader and no more than that.
hughwilson
12/8/2018
11:23
"flagship first reformulation"

agree featherby .. I said that some time ago, the market has slammed the share price because this was their first reformulation product and fair to say the one they surely were then most confident about.

So announcing a fail before half way has significantly impacted confidence in the company.

ODR

onedayrodders
12/8/2018
09:01
Jimbo yes he is quite good at responding (I even got an email not long after the end of the England Croatia game) but is obviously careful with what he says. My view is that he's made a bit of a rod for his own back by responding to multiple PIs as you then get a "Nigel said this.." and "Nigel said that..", and subjective interpretations of the same words. That does seem to be his style though so that's fair enough, I'd rather hear something than getting blanked.
dplewis1
12/8/2018
08:57
If I can be corrected and learn something when informed of my mistakes I’m very happy to listen. As I said, very little Pharma knowledge.
featherby81
12/8/2018
08:54
I think that is a big 'if'....but at least you are not stating it as fact like a certain other misleading poster!
nobbygnome
12/8/2018
08:52
Good morning Jimbobaroony, not new to investing nor Advfn but never had enough cash invested into a specific company to justify posting. N4P is my largest holding currently and look to increase once we have some feedback from the collaboration. The trial results were disappointing but I was pre advised to be prepared for trials not meeting the target and further amendments needing. I did originally join N4 for Sidenafil and not with a long term strategy but my investment research source quickly stated I needed to concentrate on the upcoming drug delivery technology.

I’m ready for the barrage of criticism by the way for this next sentence..If Nuvec continues to prove that it can sustain the particle release delay without loosing its payload in all situations with zero waste once completed, surely we could be looking at a once in a lifetime investment???.

featherby81
12/8/2018
08:50
>> featherby

I am not sure how cash isn't the issue. A reformulation and another trial is an unplanned expense plus any revenues from the drug are now much further away. That is bound to affect their financial forecasts and so it appears to me is likely to cause a cash problem. If they are negotiating deals on Nuvec, they cannot in any way be restricted by cash because then you are negotiating with one hand tied behind your back. That is why I think a fund raising is highly likely in the near future especially since they got a new broker out of the blue.

nobbygnome
12/8/2018
08:39
>>dplewis

I hadn't realised he edited my post from 21st July! So here is the full post. As you say, the editing changes the whole balance of the post! It is absolutely typical of someone who wants to mislead....

>> dplewis

Effort in, effort out. Given long enough and enough money I am pretty sure they could sort out the formulation. However, until we see what the issue was we won't know whether there is any chance of just tweaking the current formulation. I somehow doubt it but you never know.

So at the moment I think it is impossible to know the % chance in the short term.

Nobby

nobbygnome
12/8/2018
08:36
All, FYI I have exchanged a few emails with Nigel T. He seems very amenable and approachable.

The fact that Hugh claims to have contact with him is entirely reasonable. Not sure he has claimed to have any additional relationship with him (not trawling through posts to check).

jimbobaroony
12/8/2018
08:29
Nobby, you are right if it’s a full on ‘ back to the drawing board’ type of issue but until proven by the final results nobody can say how flawed the results were. Nigel’s presentations showed the 15-30 minute reaction time which is exactly where a drug in this market needs to be but critically it’s the timing inbetween inner and outer core combining as one drug that needs to be seemless (especially when fed). Cash isn’t the issue with tweaking this nor paying for another trial unless it’s a catastrophic fail which I wouldn't want to gauge or guess N4s next move.

It’s a delicate time for a new company but the reward far outweighs the risk for myself at this stage. I have limited Pharma knowledge so my positive mindset is and will be easily corrected, I’m sure.

featherby81
12/8/2018
08:23
Featherby, I notice that that you only started posting on these boards in May and only relating to N4P. What’s your background? Are you new to investing? Any Pharma experience?
jimbobaroony
12/8/2018
08:10
Sensible stance from you nobby. I'm sure you're aware you had a hatchet cut and paste job done on your posts as well - he entirely cut out the sentence starting "However.." from the 21st July post..shocking. Good luck with that apology, I'm not giving it much chance though!
dplewis1
12/8/2018
07:30
LOL you really are a sad individual. And that selection of erudite posts are supposed to prove precisely what? I paste below another post from the same time which gives my view on Pfizer and generics. As usual you are misleading people.....but hey, we have all come to expect that now.

'A low price will always win.

And as for Pfizer being interested in N4, I just spoke to my relative about that. I hope it is not giving too much away but she actually asked the Pfizer people she was dealing with about this subject because I had discussed this reformulation with her. They said that there is absolutely no interest in this form of sildenafil within Pfizer so my previous supposition that there is virtually no chance of Pfizer buying them is wrong. The chance is actually zero! They have accepted there will be reduced returns from viagra because of generic competition albeit Connect was a good effort to slow the decline.

This is where your understanding of Pharma is fatally flawed. They don't defend their drugs endlessly when there is no point, they just move on to new drugs in other areas. Generic competition is a reality of every day life for Pharma.'

So hugh I definitively have not changed my view on generics winning. An apology would be appreciated!

nobbygnome
Chat Pages: Latest  187  186  185  184  183  182  181  180  179  178  177  176  Older

Your Recent History

Delayed Upgrade Clock